{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:04:38Z","timestamp":1757624678721,"version":"3.44.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.gimo.2023.100771","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T05:25:42Z","timestamp":1679894742000},"page":"100771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vosoritide approved for treatment of linear growth in pediatric patients with achondroplasia: A\u00a0therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"1","author":[{"given":"Sheri A.","family":"Poskanzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren D.M.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyv","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gimo.2023.100771_bib1","unstructured":"Legare JM. Achondroplasia. In: Adam MP, Everman DB, Mirzaa GM, et\u00a0al, eds. GeneReviews [Internet]. University of Washington, Seattle; 1993-2023."},{"issue":"6","key":"10.1016\/j.gimo.2023.100771_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1010","article-title":"Health supervision for people with achondroplasia","volume":"145","author":"Hoover-Fong","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.gimo.2023.100771_bib3","series-title":"Cassidy and Allanson\u2019s Management of Genetic Syndromes","article-title":"Achondroplasia","author":"Pauli","year":"2020"},{"issue":"2","key":"10.1016\/j.gimo.2023.100771_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40262-021-01059-1","article-title":"Pharmacokinetics and exposure-response of vosoritide in children with achondroplasia","volume":"61","author":"Chan","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"10.1016\/j.gimo.2023.100771_bib6","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/s41436-021-01287-7","article-title":"Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study","volume":"23","author":"Savarirayan","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.gimo.2023.100771_bib7","unstructured":"U.S. National Library of Medicine. Achondroplasia. Accessed August 7, 2022. https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=achondroplasia&cntry=&state=&city=&dist="},{"issue":"12","key":"10.1016\/j.gimo.2023.100771_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244368","article-title":"In\u00a0vitro and in\u00a0vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia","volume":"15","author":"Gon\u00e7alves","year":"2020","journal-title":"PLoS One"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774423007719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774423007719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:35:59Z","timestamp":1757432159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774423007719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["S2949774423007719"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2023.100771","relation":{},"ISSN":["2949-7744"],"issn-type":[{"type":"print","value":"2949-7744"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vosoritide approved for treatment of linear growth in pediatric patients with achondroplasia: A\u00a0therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2023.100771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"100771"}}